Maria Alvarran travels from Sioux City, Nebraska, every three months to visit the Fred & Pamela Buffett Cancer Center in Omaha, Nebraska. Alvarran is helping research be the best it can be. How? By bringing diversity to potential cancer therapies. Alvarran doesn’t speak English.

The Nebraska Medicine Kearney Cancer Center is expected to open in 2024. Construction is underway in University Village, a 104-acre, mixed-use development that is a partnership with the University of Nebraska at Kearney. Located on the west edge of the UNK campus, it combines educational, residential, recreational and commercial opportunities in a pedestrian-friendly neighborhood.

Cancer care is about more than just treatment. Services that support patients’ physical, educational and emotional needs are part of a holistic approach to care during treatment.

In recent months, multiple cancer drugs have been in short supply in the United States. While the Food and Drug Administration and the American Society of Clinical Oncology have been working to resolve the shortages, patients with cancer are understandably concerned about getting the cancer treatment drugs they need and the amount required when the time comes.

Every year, nearly 80,000 new cases of melanoma are diagnosed, causing over 10,000 deaths annually. The incidence of melanoma is increasing by 2.6% every year and faster than almost every other malignancy.

Navigating breast cancer recovery can be lonely. To counter this, a nonprofit organization, Casting for Recovery, connects women who have breast cancer or a history of breast cancer through healing fly-fishing retreats.

You may have heard that sugar feeds cancer. The body needs sugar for energy. While cancer can use this energy, too, there’s more to the story.

Mohs surgery is an effective way to treat skin cancer. By pinpointing the cancer and removing it with precision, Mohs surgery gives high cure rates and allows for tissue conservation.

University of Nebraska Medical Center researchers are studying an experimental treatment for patients with specific subtypes of B-cell non-Hodgkin lymphomas. Potential candidates include patients who have undergone prior standard therapies that are no longer working or who have had cancer continue to return.

Cancer is a complex topic that includes more than 100 diseases. Research studies continue looking for answers to discover what may contribute to or cause cancer to develop in the first place.